Physician Directory
Short Bio

Ajay J Kirtane

Name and Degree:
Ajay J Kirtane, M.D., S.M.
Position:
Assistant Professor of Clinical Medicine
Background Information
Dr. Kirtane is an Interventional Cardiologist who joined the Columbia faculty after completing clinical and research fellowships in Cardiovascular Disease and Coronary and Peripheral Intervention at Harvard Medical School. He was born in Brooklyn, NY and is a graduate of Ridgewood High School in Bergen County, NJ.
Education and Training
Undergraduate:

 1990-1994 , A.B., Molecular Biology, Princeton University

Graduate:

 2004-2005 , S.M., Clinical Epidemiology, Harvard School of Public Health

Medical School:

 1994-1998 , M.D., Columbia University College of Physicians & Surgeons

Internship:

 1998-1999 , Internal Medicine, University of California - San Francisco

Residency:

 1999-2002 , Internal Medicine (Resident and Chief Medical Resident), University of California - San Francisco

Post-Graduate:

 2002-2006 , Fellowship in Cardiovascular Disease / Interventional Cardiology, Beth Israel Deaconess Med Ctr, Harvard Medical School

Board Certification: Internal Medicine (American Board of Internal Medicine)
Cardiovascular Disease (American Board of Internal Medicine)
Interventional Cardiology (American Board of Internal Medicine)
Vascular Medicine and Endovascular (American Board of Vascular Medicine)
Clinical Interests:
Interventional Cardiology including Coronary Angioplasty and Stenting,Peripheral Vascular Intervention and Vascular Medicine
Research Interests:
Dr. Kirtane's research interests are in clinical trial methodology and analysis relating to device and pharmacologic studies of cardiac and peripheral interventional procedures, as well as in the use of angiographic and biomarker outcome measures within the context of acute coronary syndromes.
Mentor(s):
Abstracts:
Publications:
1. Kirtane AJ, Piazza G, Murphy SA, Morrow DA, Cohen DJ, Peterson E, Lakkis N, Herrmann HC, Gibson CM: Correlates of Bleeding Events Among High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated with Eptifibatide: Observations from PROTECT- TIMI 30.  J Am Coll Cardiol  2006;47(12): 2374-9

2. Kirtane AJ, Leder D, Pinto DS, Karmpaliotis D, Ray KK, Burger AJ, Cannon CP, Gibson CM: An Elevated Blood Urea Nitrogen Level is Associated with Increased Mortality Independent of Serum Creatinine Among Patients with Acute Coronary Syndromes.  J Am Coll Cardiol  2005;45(11): 1781-6

3. Kirtane AJ, Vafai JJ, Murphy SA, Aroesty JM, Sabatine MS, Cannon CP, Chang A, Takao S, Braunwald E, Gibson CM: Angiographically-Apparent Thrombus following Fibrinolytic Therapy is Associated with Impaired Myocardial Perfusion in STEMI A CLARITY-TIMI 28 Substudy.  Eur Heart J  2006;27(17): 2040-5

4. Kirtane AJ, Rahman A, Martinezclark P, Jeremias A, and Manning WJ: Survey of Practice Patterns in the Management of Anticoagulation in Patients with Mechanical Valves Undergoing Elective Outpatient Procedures.  Am J Cardiol  2006;97(6): 891-3

5. Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, Cutlip DE, Bates ER, Frederick PD, Miller DP, Carrozza JP, Antman EM, Cannon CP, Gibson CM: Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy.  Circulation  2006;114: 2019-25

6. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB : Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents.  N Engl J Med  2007;356: 998-1008



Website Designed by: Web Design Studio